Feinberg is stepping down from his role as CEO and president of Geisinger Health. Geisinger is an integrated healthcare system which comprises of 13 hospitals campuses, two research centers and school of medicine.
Feinberg will now join Alphabet (Google’s parent company) in 2019 and his roles and responsibilities include: supervising diverse business units in health along with its investments in disease management and AI. Google time and again proved that it is unbeaten; this development can be an added advantage.
Google’s life science and healthcare division Verily associated with Gilead earlier this year to create a high resolution molecular map of inflammatory diseases. This partnership allowed Verily to utilize its immunological data and insights platform Immunoscape to develop the map which in turn aids in recognizing and categorizing inflammatory disease mechanisms.
Verily recently partnered with Sanofi to develop a platform named Onduo. This platform helps in simple and intelligent disease management by combining with devices, software, medicine and professional care.
Earlier in 2008, Google Health was launched but it had to end in 2011 after it failed to impress the healthcare professionals and consumers.